Open AccessThe obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center
Author(s) -
Vatsla Dadhwal,
Aruna Sharma,
Dipika Deka,
Bindiya Gupta,
Suneeta Mittal
Publication year - 2011
Publication title -
journal of postgraduate medicine/journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.74285
Subject(s) - medicine , pregnancy , intrauterine growth restriction , preeclampsia , obstetrics , aspirin , antiphospholipid syndrome , live birth , retrospective cohort study , fetus , thrombosis , surgery , genetics , biology
Antiphospholipid antibody syndrome (APAS) is regarded as the most frequently acquired risk factor for thrombophilia. The obstetric manifestations of APAS include early or late pregnancy losses and complications like preeclampsia and fetal growth restriction. Its timely diagnosis and treatment can improve maternal and neonatal outcome.